FDA Adopts 'Super Intelligence' Terminology in Public Communications Following Executive Order
The U.S. Food and Drug Administration (FDA) announced that it will begin using the term 'Super Intelligence' (SI) instead of 'artificial intelligence' (AI) in all new public-facing communications, effective November 16, 2026. This change is in compliance with Executive Order 14434, titled 'Inaugurating the Era of Super Intelligence,' issued by President Donald Trump on September 29. The executive order mandates that federal agencies replace references to AI with SI in official, non-statutory materials. The FDA clarified that this terminology shift does not alter existing submission requirements, regulations, or product names for regulated entities. The agency will continue to use original AI terminology when quoting statutes or regulations that specifically use those terms. The FDA has also launched an online SI resource hub to provide information on how it is incorporating these advanced computational technologies into its operations and supporting innovation in regulated industries.